U.S. Patents Awarded to Inventors in California (Oct. 6)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Oct. 6 -- The following federal patents were awarded to inventors in California.

*** Isis Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Isis Pharmaceuticals, Carlsbad, Calif., has been assigned a patent (8,278,425) developed by Thazha P. Prakash, Carlsbad, Calif., Balkrishin Bhat, Carlsbad, Calif., and Eric E. Swayze, Encinitas, Calif., for "N-substituted-aminomethylene bridged bicyclic nucleic acid analogs." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided herein are bicyeMc nucleosides comprising a substituted amino group in the bridge, oligomeric compounds having at least one of these bicyclic nucleosides and methods of using the oligomeric compounds. The bicyclic nucleosides comprising a substituted amino group in the bridge are useful for enhancing properties of oligomeric compounds including nuclease resistance, in certain embodiments, the oligomeric compounds hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA." The patent application was filed on May 22, 2008 (12/602,074). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,425&OS=8,278,425&RS=8,278,425 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Allergan Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Allergan, Irvine, Calif., has been assigned a patent (8,278,353) developed by five co-inventors for an "enhanced bimatoprost ophthalmic solution." The co-inventors are Chin-Ming Chang, Tustin, Calif., James N. Chang, Newport Beach, Calif., Rhett M. Schiffman, Laguna Beach, Calif., R. Scott Jordan, Trabuco Canyon, Calif., and Joan-En Chang-Lin, Tustin, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein." The patent application was filed on Feb. 10, 2012 (13/370,574). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,353&OS=8,278,353&RS=8,278,353 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** SRI International Assigned Patent ALEXANDRIA, Va., Oct. 6 -- SRI International, Menlo Park, Calif., has been assigned a patent (8,278,341) developed by four co-inventors for "analogs of indole-3-carbinol and their use as agents against infection." The co-inventors are Ling Jong, Sunnyvale, Calif., Faming Jiang, Mountain View, Calif., Gaoquan Li, Mountain View, Calif., and Kristien Mortelmans, Los Altos Hills, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compounds useful as antibacterial agents are provided. The compounds are analogs of indole-3-carbinol and have a backbone selected from dihydroindolo[2,3-b]carbazole, 2,2'-diindolylmethane, 2',3-diindolylmethane, and 3,3'-diindolylmethane. The compounds are useful therapeutic and prophylactic treatment of bacterial infections in mammals. Methods of synthesis of the compounds are provided, as are pharmaceutical compositions containing the compounds." The patent application was filed on Sept. 17, 2009 (12/561,656). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,341&OS=8,278,341&RS=8,278,341 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Xoma Techolology Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Xoma Techolology, Berkeley, Calif., has been assigned a patent (8,278,421) developed by Linda Masat, Walnut Creek, Calif., and Marina Roell, Concord, Calif., for "human antibodies specific for gastrin materials and methods." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to materials and methods for human antibodies specific for the peptide hormone gastrin and uses of these antibodies in the treatment of subjects having cancer and other conditions or disorders related to gastrin expression." The patent application was filed on Dec. 13, 2006 (12/293,890). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,421&OS=8,278,421&RS=8,278,421 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** VertiFlex Assigned Patent ALEXANDRIA, Va., Oct. 6 -- VertiFlex, San Clemente, Calif., has been assigned a patent (8,277,488) developed by six co-inventors for an interspinous spacer. The co-inventors are Moti Altarac, Irvine, Calif., Shawn Tebbe, Oceanside, Calif., Joey Camia Reglos, Lake Forest, Calif., Yang Cheng, Foothill Ranch, Calif., Murali P. Kadaba, Foster City, Calif., and Daniel H. Kim, Houston.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "An implantable spacer for placement between adjacent spinous processes in a spinal motion segment is provided. The spacer includes a body defining a longitudinal axis and passageway. A first arm and a second arm are connected to the body. Each arm has a pair of extensions and a saddle defining a U-shaped configuration for seating a spinous process therein. Each arm has a proximal caming surface and is capable of rotation with respect to the body. An actuator assembly is disposed inside the passageway and connected to the body. When advanced, a threaded shaft of the actuator assembly contacts the caming surfaces of arms to rotate them from an undeployed configuration to a deployed configuration. In the deployed configuration, the distracted adjacent spinous processes are seated in the U-shaped portion of the arms." The patent application was filed on July 24, 2008 (12/220,427). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=82,77,488.PN.&OS=PN/82,77,488&RS=PN/82,77,488 Written by Amal Ahmed; edited by Jaya Anand.

*** AREVA Solar Assigned Patent ALEXANDRIA, Va., Oct. 6 -- AREVA Solar, Mountain View, Calif., has been assigned a patent (8,277,592) developed by eight co-inventors for a "method of shaping a reflector." The co-inventors are Alexander F. Hoermann, Menlo Park, Calif., David B. DeGraaf, Mountain View, Calif., James L. Barnhart, Sunnyvale, Calif., David John McKay, Mountain View, Calif., Daniel Crenshaw, Los Gatos, Calif., Scott P. Phillips, Marina Del Rey, Calif., Forest Ray, Redwood City, Calif., and Seung Lim, Santa Cruz, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A mirror is shaped using a shaping apparatus including a crossbar and a horizontal array of members (wheels in some embodiments) attached to a bottom of the crossbar. The height of the array of members is adjusted to form a predetermined shape. The shaping apparatus is positioned over a mirror such that the members contact the mirror. The shaping apparatus is moved along a length of the mirror such that the members remain in contact with the mirror. A frame is attached to the mirror such that when the shaping apparatus is removed from the mirror, the mirror substantially retains the predetermined shape." The patent application was filed on March 27, 2009 (12/413,367). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=82,77,592.PN.&OS=PN/82,77,592&RS=PN/82,77,592 Written by Amal Ahmed; edited by Jaya Anand.

*** Henkel Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Henkel, Rocky Hill, Conn., has been assigned a patent (8,278,396) developed by Pukun Zhu, Irvine, Calif., and Puwei Liu, San Marcos, Calif., for "curing agents for epoxy resins." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A curing agent for epoxy resin has one or more five- or six-membered aromatic rings, and substituted on the one or more five- or six-membered rings at least two functionalities reactive with the epoxy selected from the group consisting of hydroxyl, amine, imidazole, azine, hydrazide, anhydride, and Lewis acid groups. Choice of functionality can provide a mixed polymer network, one with a more densely cross-linked polymer structure having a high Tg, and the other with a more linear polymer structure to contribute to stress reduction." The patent application was filed on May 13, 2011 (13/106,924). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,396&OS=8,278,396&RS=8,278,396 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Lam Research Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Lam Research, Fremont, Calif., has been assigned a patent (8,277,604) developed by Arthur M. Howald, Pleasanton, Calif., and Andras Kuthi, Thousand Oaks, Calif., for an "antenna for plasma processor and apparatus." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An antenna includes excitation terminals responsive to an RF source to supply an RF electromagnetic field to a plasma that processes a workpiece in a vacuum chamber. The coil includes a transformer having a primary winding coupled to the excitation terminals and a multi-turn plasma excitation secondary winding connected in series with a capacitor." The patent application was filed on Feb. 3, 2011 (13/020,170). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=82,77,604.PN.&OS=PN/82,77,604&RS=PN/82,77,604 Written by Amal Ahmed; edited by Jaya Anand.

*** Onike Technologies Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Onike Technologies, Rolling Hills Estates, Calif., has been assigned a patent (8,277,492) developed by Lytton A. Williams, Rolling Hills Estates, Calif., for a "bone anchored surgical mesh." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A bone-anchored surgical mesh has slot-like anchoring members that allow for the variable placement of screws and other bone fasteners. This permits the surgeon discretion in the placement of bone fasteners used to attach the mesh to the patient's bone. The elongate openings of the anchoring members allow for a sliding motion between the bone fasteners and the anchoring members, and facilitates positioning and articulation of the mesh. The anchoring members may include bushings to aid the sliding motion of the anchoring member on the bone fastener. In one embodiment, the mesh consists of shorter modular strips that overlap each other such that a single bone fastener is passed through two overlapping anchoring members to lock the two modular mesh strips together. Additional modular mesh strips can be added on at either end, as desired, to provide the desired length of dural coverage." The patent application was filed on Sept. 24, 2010 (12/890,375). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=82,77,492.PN.&OS=PN/82,77,492&RS=PN/82,77,492 Written by Amal Ahmed; edited by Jaya Anand.

*** Material Innovations Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Material Innovations, Providence, R.I., has been assigned a patent (8,278,365) developed by David E. Murdock, Dublin, Ohio, Douglas Mancosh, Warwick, R.I., and James P. Przybylinski, St. Helena, Calif., for a carpet waste composite.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A composite material is produced from carpet waste and a binding agent, in intimate association, and may also include wood fiber or chips and/or other additives. A method of manufacturing a composite material includes shredding carpet waste, coating the carpet waste with a binding agent, and subjecting the shredded, coated carpet waste to elevated heat and pressure. As an additional step, the composite material may be actively cooled to prevent deformation of the material." The patent application was filed on March 22, 2011 (13/053,837). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,365&OS=8,278,365&RS=8,278,365 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Stanford University Assigned Patent for Methods and Devices for Manipulating the Thermoregulatory Status of a Mammal ALEXANDRIA, Va., Oct. 6 -- Stanford University, Palo Alto, Calif., has been assigned a patent (8,277,496) developed by Dennis A. Grahn, Palo Alto, Calif., and H. Craig Heller, Stanford, Calif., for "methods and devices for manipulating the thermoregulatory status of a mammal." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and devices for manipulating the thermoregulatory status of a mammal are provided. In the subject methods, thermal energy is transferred between the environment and both of the thoracic/abdominal core body and head of the mammal. In general, thermal energy transfer between thoracic/abdominal core body and the environment occurs under negative pressure conditions. The subject methods and devices can be used to increase the thoracic/abdominal core body temperature of a mammal, in which case thermal energy is introduced into the thoracic/abdominal core body of the mammal and removed from the head of the mammal or cold is merely applied thereto. The subject methods and devices can also be used to reduce the thoracic/abdominal core body temperature of a mammal, in which case thermal energy is removed from the thoracic/abdominal core body of the mammal and introduced into the head of the mammal or heat is merely applied thereto." The patent application was filed on Jan. 23, 2007 (11/657,188). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=82,77,496.PN.&OS=PN/82,77,496&RS=PN/82,77,496 Written by Amal Ahmed; edited by Jaya Anand.

*** Ambrx Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Ambrx, La Jolla, Calif., has been assigned a patent (8,278,418) developed by 10 co-inventors for "modified animal erythropoietin polypeptides and their uses." The co-inventors are Feng Tian, San Diego, Anna-Maria A. Hays Putnam, San Diego, Frank Song, San Diego, Stephanie Chu, San Diego, Joseph Sheffer, Cardiff, Calif., Richard S. Barnett, San Marcos, Calif., Marc E. Siladi, San Diego, Kyle Atkinson, San Diego, Darin Lee, San Diego, and Peter C. Canning, Noblesville, Ind.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Modified animal erythropoietin polypeptides and uses thereof are provide." The patent application was filed on Sept. 25, 2009 (12/567,627). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,418&OS=8,278,418&RS=8,278,418 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** LAM Research Assigned Patent ALEXANDRIA, Va., Oct. 6 -- LAM Research, Fremont, Calif., has been assigned a patent (8,277,570) developed by Seokmin Yun, Pleasanton, Calif., and Mark Wilcosson, Oakland, Calif., for a "method of preventing premature drying." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for processing a substrate includes receiving a substrate and processing the substrate using a first fluid meniscus and a second fluid meniscus. The first fluid meniscus and the second fluid meniscus are applied to a surface of the substrate such that the first fluid meniscus is spaced apart from the second fluid meniscus by a transition region. A saturated gas chemistry is applied to the surface of the substrate at the transition region. The saturated gas chemistry is configured to maintain moisture in the transition region so as to prevent drying of the surface of the substrate in the transition region, before the second fluid meniscus is applied to the surface of the substrate." The patent application was filed on Aug. 10, 2011 (13/207,405). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=82,77,570.PN.&OS=PN/82,77,570&RS=PN/82,77,570 Written by Amal Ahmed; edited by Jaya Anand.

*** Agensys Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Agensys, Santa Monica, Calif., has been assigned a patent (8,278,424) developed by eight co-inventors for "antibodies that bind to PSCA proteins for diagnosis of cancer." The co-inventors are Jean Gudas, Los Angeles, Aya Jakobovits, Beverly Hills, Calif., Xiao-chi Jia, Los Angeles, Robert Kendall Morrison, Santa Monica, Calif., Karen Jane Meyrick Morrison, Santa Monica, Calif., Hui Shao, Los Angeles, Pia M. Challita-Eid, Encino, Calif., and Arthur B. Raitano, Los Alamitos, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Antibodies and molecules derived therefrom that bind to novel PSCA protein, and variants thereof, are described wherein PSCA exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, PSCA provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The PSCA gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with PSCA can be used in active or passive immunization." The patent application was filed on April 26, 2011 (13/094,730). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,424&OS=8,278,424&RS=8,278,424 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Stanford University Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Stanford University, Palo Alto, Calif., has been assigned a patent (8,277,628) developed by Mostafa Ronaghi, Los Altos Hills, Calif., Tarun Khurana, Stanford, Calif., and Juan G. Santiago, Stanford, Calif., for a "method and apparatus using electric field for improved biological assays." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed are a method and apparatus that use an electric field for improved biological assays. The electric field is applied across a device having wells, which receive reactants, which carry a charge. The device thus uses a controllable voltage source between the first and second electrodes, which is controllable to provide a positive charge and a negative charge to a given electrode. By controlled use of the electric field charged species in a fluid in a fluid channel are directed into or out of the well by an electric field between the electrodes. The present method involves the transport of fluids, as in a microfluidic device, and the electric field-induced movement of reactive species according to various assay procedures, such as DNA sequencing, synthesis or the like." The patent application was filed on July 10, 2008 (12/170,941). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=82,77,628.PN.&OS=PN/82,77,628&RS=PN/82,77,628 Written by Amal Ahmed; edited by Jaya Anand.

*** REVA Medical Assigned Patent ALEXANDRIA, Va., Oct. 6 -- REVA Medical, San Diego, has been assigned a patent (8,277,500) developed by Eric Schmid, San Diego, Andrew Morris, San Diego, and John D. Nguyen, San Diego, for a slide-and-lock stent.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention relates to an expandable stent comprising circumferentially adjacent modules. The modules comprise longitudinally adjacent slide-and-lock radial elements which permit one-way sliding of the radial elements from a collapsed diameter to an expanded/deployed diameter, but inhibit radial recoil from the expanded diameter." The patent application was filed on June 20, 2006 (11/455,986). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=82,77,500.PN.&OS=PN/82,77,500&RS=PN/82,77,500 Written by Amal Ahmed; edited by Jaya Anand.

*** Advanced Cardiovascular Systems Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Advanced Cardiovascular Systems, Santa Clara, Calif., has been assigned a patent (8,277,498) developed by Anthony J. Abbate, Santa Clara, Calif., and Jeffrey David Royal, San Francisco, for a "system for delivery of a stent at an elevated temperature." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and systems of delivering a stent at an elevated temperature are disclosed herein." The patent application was filed on April 20, 2011 (13/090,537). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=82,77,498.PN.&OS=PN/82,77,498&RS=PN/82,77,498 Written by Amal Ahmed; edited by Jaya Anand.

*** Allergan Assigned Patent for Therapeutic Compounds ALEXANDRIA, Va., Oct. 6 -- Allergan, Irvine, Calif., has been assigned a patent (8,278,347) developed by Yariv Donde, Dana Point, Calif., and Jeremiah H. Nguyen, La Puente, Calif., for therapeutic compounds.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A compound having a structure ##STR00001## is disclosed herein. Compositions, medicaments, and therapeutic methods related thereto are also disclosed." The patent application was filed on July 5, 2011 (13/176,427). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,347&OS=8,278,347&RS=8,278,347 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** SanDisk Technologies Assigned Patent for Metal Control Gate Formation in Non-volatile Storage ALEXANDRIA, Va., Oct. 6 -- SanDisk Technologies, Plano, Texas, has been assigned a patent (8,278,203) developed by Jarrett Jun Liang, San Francisco, Vinod Robert Purayath, Santa Clara, Calif., and Takashi Whitney Orimoto, Sunnyvale, Calif., for a "metal control gate formation in non-volatile storage." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods for fabricating control gates in non-volatile storage are disclosed. When forming stacks for floating gate memory cells and transistor control gates, a sacrificial material may be formed at the top of the stacks. After insulation is formed between the stacks, the sacrificial material may be removed to reveal openings. In some embodiments, cutouts are then formed in regions in which control gates of transistors are to be formed. Metal is then formed in the openings, which may include the cutout regions. Therefore, floating gate memory cells having at least partially metal control gates and transistors having at least partially metal control gates may be formed in the same process. A barrier layer may be formed prior to depositing the metal in order to prevent silicidation of polysilicon in the control gates." The patent application was filed on July 28, 2010 (12/845,329). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,203&OS=8,278,203&RS=8,278,203 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Durect Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Durect, Cupertino, Calif., has been assigned a patent (8,278,330) developed by Guohua Chen, Sunnyvale, Calif., and David Priebe, Mountain View, Calif., for "short duration depot formulations." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, depot gel compositions that can be injected into a desired location and which can provide controlled release of a beneficial agent over a short duration of time. The compositions include a low molecular weight biocompatible polymer, a biocompatible solvent having low water miscibility that forms a viscous gel with the polymer and limits water uptake by the implant, and a beneficial agent." The patent application was filed on Sept. 27, 2010 (12/924,441). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,330&OS=8,278,330&RS=8,278,330 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Solazyme Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Solazyme, South San Francisco, Calif., has been assigned a patent (8,278,261) developed by Anthony G. Day, San Francisco, Geoffrey Brooks, Reno, Nev., and Scott Franklin, San Diego, for "method of making soaps from oil-bearing microbial biomass and oils." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Soap and cosmetic products can be made from oil-bearing microbial biomass via the alkaline hydrolysis of glycerolipids and fatty acid esters to fatty acid salts. The saponified microbial oils/lipids can be combined with a variety of additives to produce compositions for use as soaps and other cosmetic products, which may also contain other constituents of the biomass, including unsaponified oils, glycerol and carotenoids, among others." The patent application was filed on Feb. 3, 2012 (13/366,198). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,261&OS=8,278,261&RS=8,278,261 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Solexel Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Solexel, Milpitas, Calif., has been assigned a patent (8,278,192) developed by David Xuan-Qi Wang, Fremont, Calif., and Mehrdad Moslehi, Los Altos, Calif., for a "trench formation method for releasing a thin-film substrate from a reusable semiconductor template." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method is provided for fabricating a thin-film semiconductor substrate by forming a porous semiconductor layer conformally on a reusable semiconductor template and then forming a thin-film semiconductor substrate conformally on the porous semiconductor layer. An inner trench having a depth less than the thickness of the thin-film semiconductor substrate is formed on the thin-film semiconductor substrate. An outer trench providing access to the porous semiconductor layer is formed on the thin-film semiconductor substrate and is positioned between the inner trench and the edge of the thin-film semiconductor substrate. The thin-film semiconductor substrate is then released from the reusable semiconductor template." The patent application was filed on Feb. 8, 2010 (12/702,187). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,192&OS=8,278,192&RS=8,278,192 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Novellus Systems Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Novellus Systems, San Jose, Calif., has been assigned a patent (8,278,216) developed by four co-inventors for a "selective capping of copper." The co-inventors are Glenn Alers, Scotts Valley, Calif., Nerissa Draeger, Fremont, Calif., Michael Carolus, Milpitas, Calif., and Julie Carolus legal representative, Pasadena, Texas.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides methods of selectively depositing refractory metal and metal nitride cap layers onto copper lines inlaid in a dielectric layer. The methods result in formation of a cap layer on the copper lines without significant formation on the surrounding dielectric material. The methods typically involve exposing the copper lines to a nitrogen-containing organo-metallic precursor and a reducing agent under conditions that the metal or metal nitride layer is selectively deposited. In a particular embodiment, an amino-containing tungsten precursor is used to deposit a tungsten nitride layer. Deposition methods such as CVD or ALD may be used." The patent application was filed on Aug. 18, 2006 (11/506,761). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,216&OS=8,278,216&RS=8,278,216 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Protox Therapeutics Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Protox Therapeutics, La Jolla, Calif., has been assigned a patent (8,278,279) developed by J. Curtis Nickel, Sydenham, Calif., for a "method for treating prostatitis utilizing modified pore-forming protein proaerolysin." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present disclosure includes methods and compositions for treating any condition involving prostatitis and similar diseases and/or conditions. These methods and compositions involve the use of targeted modified pore-forming proteins, including variant proaerolysin proteins." The patent application was filed on Dec. 15, 2009 (13/139,928). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,279&OS=8,278,279&RS=8,278,279 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Amgen Assigned Patent for Antagonists of the Bradykinin B1 Receptor ALEXANDRIA, Va., Oct. 6 -- Amgen, Thousand Oaks, Calif., has been assigned a patent (8,278,280) developed by 10 co-inventors for "antagonists of the bradykinin B1 receptor." The co-inventors are Gordon Ng, Newbury Park, Calif., Yue-Sheng Li, Thousand Oaks, Calif., Colin V. Gegg, Newbury Park, Calif., Benny C. Askew Jr., Marshfield, Mass., Thomas Storz, Warwick, N.Y., Yuelie Lu, Belle Mead, N.J., Derin C. D'Amico, Newbury Park, Calif., Mark A. Jarosinski, Fishers, Ind., Chuan-Fa Liu, Waltham, Mass., and Qi Huang, Moorpark, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to composition of matter involving bradykinin B1 receptor antagonist peptides conjugated to a multivalent vehicle, including peptides conjugated to multivalent PEG. These compositions can be used as therapeutics or prophylactics against diseases or conditions, such as inflammation or pain, linked to the bradykinin B1 receptor." The patent application was filed on April 8, 2008 (12/082,219). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,280&OS=8,278,280&RS=8,278,280 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Novellus Systems Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Novellus Systems, San Jose, Calif., has been assigned a patent (8,278,224) developed by Collin K.L. Mui, Mountain View, Calif., Lakshminarayana Nittala, Sunnyvale, Calif., and Nerissa S. Draeger, Fremont, Calif., for "flowable oxide deposition using rapid delivery of process gases." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and apparatus for filling gaps on partially manufactured semiconductor substrates with dielectric material are provided. In certain embodiments, the methods include introducing a first process gas into the processing chamber and accumulating a second process gas in an accumulator maintained at a pressure level substantially highest than that of the processing chamber pressure level. The second process gas is then rapidly introduced from the accumulator into the processing chamber. An excess amount of the second process gas may be provided in the processing chamber during the introduction of the second process gas. Flowable silicon-containing films forms on a surface of the substrate to at least partially fill the gaps." The patent application was filed on Sept. 24, 2009 (12/566,085). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,224&OS=8,278,224&RS=8,278,224 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Applied Materials Assigned Patent for Passivating Glue Layer to Improve Amorphous Carbon to Metal Adhesion ALEXANDRIA, Va., Oct. 6 -- Applied Materials, Santa Clara, Calif., has been assigned a patent (8,278,139) developed by Siu F. Cheng, San Jose, Calif., and Deenesh Padhi, Sunnyvale, Calif., for a "passivating glue layer to improve amorphous carbon to metal adhesion." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and apparatus is provided for forming a resistive memory device having good adhesion among the components thereof. A first conductive layer is formed on a substrate, and the surface of the first conductive layer is treated to add adhesion promoting materials to the surface. The adhesion promoting materials may form a layer on the surface, or they may incorporate into the surface or merely passivate the surface of the first conductive layer. A variable resistance layer is formed on the treated surface, and a second conductive layer is formed on the variable resistance layer. Adhesion promoting materials may also be included at the interface between the variable resistance layer and the second conductive layer." The patent application was filed on Sept. 25, 2009 (12/566,948). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,139&OS=8,278,139&RS=8,278,139 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Isis Pharmaceuticals Assigned Patent for 6-disubstituted or Unsaturated Bicyclic Nucleic Acid Analogs ALEXANDRIA, Va., Oct. 6 -- Isis Pharmaceuticals, Carlsbad, Calif., has been assigned a patent (8,278,283) developed by Punit P. Seth, Carlsbad, Calif., and Eric E. Swayze, Encinitas, Calif., for "6-disubstituted or unsaturated bicyclic nucleic acid analogs." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present disclosure describes 6-disubstituted bicyclic nucleosides, oligomeric compounds prepared therefrom and methods of using the oligomeric compounds. More particularly, the 6-disubstituted bicyclic nucleosides each comprise a 2'-O--C(Ri)(R2)-4' or 2'-O--C=(R3)(R.4)-4' bridge wherein each R is, independently a substituent group and Ri and R2 include H. The 6-disubstituted bicyclic nucleosides are useful for enhancing properties of oligomeric compounds including nuclease resistance. In certain embodiments, the oligomeric compounds provided herein hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA." The patent application was filed on July 1, 2008 (12/667,684). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,283&OS=8,278,283&RS=8,278,283 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Georgia Tech Research Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Georgia Tech Research, Atlanta, has been assigned a patent (8,278,191) developed by Owen Hildreth, Pacific Grove, Calif., Ching Ping Wong, Berkeley Lake, Ga., and Yonghao Xiu, Santa Clara, Calif., for "methods and systems for metal-assisted chemical etching of substrates." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed herein are various embodiments related to metal-assisted chemical etching of substrates on the micron, sub-micron and nano scales. In one embodiment, among others, a method for metal-assisted chemical etching includes providing a substrate; depositing a non-spherical metal catalyst on a surface of the substrate; etching the substrate by exposing the non-spherical metal catalyst and the substrate to an etchant solution including a composition of a fluoride etchant and an oxidizing agent; and removing the etched substrate from the etchant solution." The patent application was filed on March 31, 2010 (12/751,080). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,191&OS=8,278,191&RS=8,278,191 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Rigel Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Rigel Pharmaceuticals, South San Francisco, Calif., has been assigned a patent (8,278,299) developed by 10 co-inventors for pyrimidinediamine kinase inhibitors. The co-inventors are Rajinder Singh, Belmont, Calif., Andy Atuegbu, Dublin, Calif., John Ramphal, Union City, Calif., Hui Li, Santa Clara, Calif., Marina Gelman, San Francisco, Jeffrey Clough, Redwood City, Calif., Carlos Valdez, San Ramon, Calif., Somasekhar Bhamidipati, Foster City, Calif., Sambaiah Thota, Woburn, Mass., and Darren McMurtrie, Foster City, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides pyrimidinediamine compounds useful for inhibiting kinase activity, including the activity of polo-like kinase 1 (PLK1). Also provided are pharmaceutical compositions comprising these compounds and methods of treating diseases associated with kinase activity, in particular enhanced PLK1 catalytic activity, such as diseases associated with abnormal cell proliferation, including neoplastic disorders." The patent application was filed on Dec. 29, 2009 (12/649,073). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,299&OS=8,278,299&RS=8,278,299 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** International Business Machines Assigned Patent for Reprogrammable Fuse Structure and Method ALEXANDRIA, Va., Oct. 6 -- International Business Machines, Armonk, N.Y., has been assigned a patent (8,278,155) developed by seven co-inventors for a "reprogrammable fuse structure and method." The co-inventors are Geoffrey W. Burr, Cupertino, Calif., Chandrasekharan Kothandaraman, Hopewell Junction, N.Y., Chung Hon Lam, Peekskill, N.Y., Xiao Hu Liu, Briarcliff Manor, N.Y., Stephen M. Rossnagel, Pleasantville, N.Y., Christy S. Tyberg, Mahopac, N.Y., and Robert L. Wisnieff, Ridgefield, Conn.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A reversible fuse structure in an integrated circuit is obtained through the implementation of a fuse cell having a short thin line of phase change materials in contact with via and line structures capable of passing current through the line of phase change material (fuse cell). The current is passed through the fuse cell in order to change the material from a less resistive material to a more resistive material through heating the phase change material in the crystalline state to the melting point then quickly quenching the material into the amorphous state. The reversible programming is achieved by passing a lower current through the fuse cell to convert the high resistivity amorphous material to a lower resistivity crystalline material. Appropriate sense-circuitry is integrated to read the information stored in the fuses, wherein said sense circuitry is used to enable or disable circuitry." The patent application was filed on May 4, 2011 (13/100,456). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,155&OS=8,278,155&RS=8,278,155 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** FibroGen Assigned Patent ALEXANDRIA, Va., Oct. 6 -- FibroGen, San Francisco, has been assigned a patent (8,278,325) developed by six co-inventors for "nitrogen-containing heteroaryl compounds and methods of use thereof." The co-inventors are Michael P. Arend, San Mateo, Calif., Lee A. Flippin, Woodside, Calif., Volkmar Guenzler-Pukall, San Leandro, Calif., Wen-Bin Ho, Los Altos, Calif., Eric Turtle, Belmont, Calif., and Xiaohui Du, Foster City, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo." The patent application was filed on July 19, 2011 (13/186,351). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,325&OS=8,278,325&RS=8,278,325 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Amylin Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Amylin Pharmaceuticals, San Diego, has been assigned a patent (8,278,267) developed by four co-inventors for a "method of modifying food preference comprising administering amylin or amylin agonist." The co-inventors are Christian Weyer, San Diego, Kevin D. Laugero, Davis, Calif., Christine M. Mack, Ventura, Calif., and David G. Parkes, Del Mar, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet and nutrition are provided. The methods provided generally involve the administration of an Amylin or an Amylin agonist to a subject in order to prevent, treat or control conditions or disorders associated with obesity, diet and nutrition." The patent application was filed on Dec. 9, 2010 (12/964,516). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,267&OS=8,278,267&RS=8,278,267 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Intermolecular Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Intermolecular, San Jose, Calif., has been assigned a patent (8,278,215) developed by four co-inventors for a "noble metal activation layer." The co-inventors are Zhi-Wen Sun, San Jose, Calif., Bob Kong, San Jose, Calif., Igor Ivanov, Danville, Calif., and Tony Chiang, Campbell, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Processes for minimizing contact resistance when using nickel silicide (NiSi) and other similar contact materials are described. These processes include optimizing silicide surface cleaning, silicide surface passivation against oxidation and techniques for diffusion barrier/catalyst layer deposition. Additionally, processes for generating a noble metal (for example platinum, iridium, rhenium, ruthenium, and alloys thereof) activation layer that enables the electroless barrier layer deposition on a NiSi-based contact material are described. The processes may be employed when using NiSi-based materials in other end products. The processes may be employed on silicon-based materials." The patent application was filed on May 2, 2011 (13/098,926). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,215&OS=8,278,215&RS=8,278,215 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Kai Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Kai Pharmaceuticals, South San Francisco, Calif., has been assigned a patent (8,278,264) developed by five co-inventors for "compositions and methods for enhancing drug delivery across and into ocular tissues." The co-inventors are Jonathan B. Rothbard, Cupertino, Calif., Paul A. Wender, Menlo Park, Calif., P. Leo McGrane, Mountain View, Calif., Lalitha V.S. Sista, Sunnyvale, Calif., and Thorsten A. Kirschberg, Mountain View, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention provides compositions and methods for enhancing delivery of drugs and other agents across epithelial tissues, including into and across ocular tissues and the like. The compositions and methods are also useful for delivery across endothelial tissues, including the blood brain barrier. The compositions and methods employ a delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue, compared to the non-conjugated compound. The delivery-enhancing polymers include, for example, poly-arginine molecules that are preferably between about 6 and 25 residues in length (for example, SEQ ID NO:86)." The patent application was filed on May 4, 2007 (11/800,358). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,264&OS=8,278,264&RS=8,278,264 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Fairchild Semiconductor Assigned Patent for Package with Multiple Dies ALEXANDRIA, Va., Oct. 6 -- Fairchild Semiconductor, South Portland, Maine, has been assigned a patent (8,278,149) developed by David Grey, Santa Clara, Calif., for "package with multiple dies." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A semiconductor die package is disclosed. It includes a leadframe structure comprising a first die attach pad and a second die attach pad. A plurality of leads extend from the first and second die attach pads. The plurality of leads includes at least a first control lead and a second control lead. A first semiconductor die including a first device is mounted on the first die attach pad, and a second semiconductor die has a second device is mounted on the second die attach pad. A housing is provided in the semiconductor die package and protects the first and second dies. The housing may have an exterior surface and at least partially covers the first semiconductor die and the second semiconductor die. The first control lead and the second control lead are at opposite sides of the semiconductor die package." The patent application was filed on July 16, 2010 (12/838,022). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,149&OS=8,278,149&RS=8,278,149 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Cadence Design Systems Assigned Patent for Spacer Double Patterning for Lithography Operations ALEXANDRIA, Va., Oct. 6 -- Cadence Design Systems, San Jose, Calif., has been assigned a patent (8,278,156) developed by Christophe Pierrat, Santa Clara, Calif., for a "spacer double patterning for lithography operations." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Systems and methods of semiconductor device fabrication and layout generation are disclosed. An exemplary method includes processes of depositing a layer of a first material and patterning the layer to form an initial pattern, wherein the initial pattern defines critical features of the layout elements using a single exposure; depositing spacer material over the first pattern on the substrate and etching the spacer material such that the spacer material is removed from horizontal surfaces of the substrate and the first pattern but remains adjacent to vertical surfaces of the first pattern; removing the initial pattern from the substrate while leaving the spacer material in a spacer pattern; filling the spacer pattern with final material; and trimming the tilled pattern to remove portions of the final material beyond dimensions of the layout elements." The patent application was filed on Sept. 23, 2010 (12/889,133). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,156&OS=8,278,156&RS=8,278,156 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Actimis Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Actimis Pharmaceuticals, La Jolla, Calif., has been assigned a patent (8,278,310) developed by Tai Wei Ly, San Diego, for "amine salts of a CRTH2 antagonist." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided are amine salts of {4,6-bis(dimethylamino)-2-(4-(4-(trifluoromethyl)benzamido)benzyl)pyrimid- in-5-yl}-acetic acid, processes for their preparation, pharmaceutical compositions containing them, and their use for treating, preventing, or ameliorating one or more symptoms of a CRTH2-mediated disorder or disease." The patent application was filed on June 18, 2008 (12/665,705). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,310&OS=8,278,310&RS=8,278,310 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Sangart Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Sangart, San Diego, has been assigned a patent (8,278,275) developed by Robert M. Winslow, La Jolla, Calif., and Kim D. Vandegriff, San Diego, for "method to enhance hemodynamic stability using oxygen carrying compositions." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to methods for enhancing the hemodynamic stability of an individual undergoing surgery by administering a composition comprising a hemoglobin-based oxygen carrier. In one embodiment, the present invention relates to the use of polyalkylene oxide modified hemoglobins with reduced cooperativity and a high oxygen affinity to enhance oxygen offloading as a preventative measure to avoid hemodynamic stability-related complications during surgery." The patent application was filed on Nov. 23, 2009 (12/623,760). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,278,275&OS=8,278,275&RS=8,278,275 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Raytheon Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Raytheon, Waltham, Mass., has been assigned a patent (8,278,979) developed by William D. Farwell, Thousand Oaks, Calif., for a "digital circuits with adaptive resistance to single event upset." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A digital circuit with adaptive resistance to single event upset. A novel transient filter is placed within the feedback loop of each latch in the digital circuit to reject pulses having a width less than T, where T is the longest anticipated duration of transients. The transient filter includes a first logic element having a controllable inertial delay and a second logic element coupled to an output of the first logic element. A first controller provides a control voltage VcR to each first logic element to control a rise time of the first logic element to be equal to T. A second controller provides a control voltage VcF to each first logic element to control a fall time of the first logic element to be equal to T." The patent application was filed on Sept. 9, 2010 (12/878,944). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,278,979.PN.&OS=PN/8,278,979&RS=PN/8,278,979 Written by Kusum Sangma; edited by Anand Kumar.

*** Magnetic-Electrostatic Confinement (MEC) Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Magnetic-Electrostatic Confinement (MEC), Glenbrook, Nev., has been assigned a patent (8,279,030) developed by Devlin Baker, Bellingham, Wash., and Daniel Bateman, San Francisco, for a "method and apparatus for electrical, mechanical and thermal isolation of superconductive magnets." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and apparatus of electrical, mechanical and thermal isolation of superconductive magnet coils includes a superconductive magnet for environments wherein large differences of electrical potential between the interior superconductive winding and the exterior of the device, on the order of 10.sup.3to 10.sup.6 Volts may exist. The methods and apparatus also includes insulation, cooling, and structural elements such that the interior of the device is capable of maintaining cryogenic temperatures needed for superconductivity, even in the presence of high heat flux incident on the overall winding housing. Finally, a device includes structural elements for support against gravity and other forces exerted on the assembly that include expansion jointing and stabilization to minimize warping or bending of the assembly due to temperature gradients. These supports include accoutrements for supplying electrical power, cryogenic coolant, and other supply leads to the magnet head, while also being isolated from thermal and electrical effects." The patent application was filed on Sept. 26, 2009 (12/567,765). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,279,030.PN.&OS=PN/8,279,030&RS=PN/8,279,030 Written by Kusum Sangma; edited by Anand Kumar.

*** National Semiconductor Assigned Patent ALEXANDRIA, Va., Oct. 6 -- National Semiconductor, Santa Clara, Calif., has been assigned a patent (8,278,995) developed by Luan Vu, San Jose, Calif., and Elroy Lucero, San Jose, Calif., for a "bandgap in CMOS DGO process." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Bandgap voltage reference circuitry capable of operating at very low power supply voltages. The current source for driving the core bandgap voltage reference is implemented with insulated gate field effect transistors having low threshold voltages. Voltage clamp circuitry protects the transistors from power supply voltage variations rising above a predetermined clamp voltage. An output amplifier with output biasing circuitry having a circuit structure similar to that of the core bandgap voltage reference ensures that the bandgap reaches the intended steady state of operation." The patent application was filed on Jan. 12, 2011 (13/005,378). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,278,995.PN.&OS=PN/8,278,995&RS=PN/8,278,995 Written by Kusum Sangma; edited by Anand Kumar.

*** Vical Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Vical, San Diego, has been assigned a patent (8,278,093) developed by Gary G. Hermanson, Encinitas, Calif., Andrew J. Geall, Cambridge, Mass., and Mary Kopke Wloch, San Diego, for a "codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention is related to polynucleotide-based cytomegalovirus vaccines. In particular, the invention is plasmids operably encoding HCMV antigens, in which the naturally-occurring coding regions for the HCMV antigens have been modified for improved translation in human or other mammalian cells through codon optimization. HCMV antigens which are useful in the invention include, but are not limited to pp65, glycoprotein B (gB), IE1, and fragments, variants or derivatives of either of these antigens. In certain embodiments, sequences have been deleted, e.g., the Arg435-Lys438 putative kinase in pp65 and the membrane anchor and endocellular domains in gB. The invention is further directed to methods to induce an immune response to HCMV in a mammal, for example, a human, comprising delivering a plasmid encoding a codon-optimized HCMV antigen as described above. The invention is also directed to pharmaceutical compositions comprising plasmids encoding a codon-optimized HCMV antigen as described above, and further comprising adjuvants, excipients, or immune modulators." The patent application was filed on Jan. 25, 2011 (13/013,752). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,278,093.PN.&OS=PN/8,278,093&RS=PN/8,278,093 Written by Kusum Sangma; edited by Anand Kumar.

*** Alien Technology Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Alien Technology, Morgan Hill, Calif., has been assigned a patent (8,279,047) developed by five co-inventors for "methods and apparatus for anti-collision for radio frequency communication." The co-inventors are Curt Carrender, Morgan Hill, Calif., John M. Price, Morgan Hill, Calif., Frederick A. Nylander, Morgan Hill, Calif., John H. Rolin, Morgan Hill, Calif., and Roger G. Stewart, Morgan Hill, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "An identification system includes a reader and one or more tags. The reader identifies tags such as radio frequency (RF) tags. The system divides a number space into n bins, wherein each bin is associated with m unique bits of the number space, and the number space contains the identification codes of the tags. A command is issued to test v bits of the number space. A response is received from a tag, wherein the response occurs when a first portion of an identification code of the tag matches the v bits of the number space, a timing of the response corresponds to a particular bin and m unique bits associated with the particular bin correspond to a second portion of the identification code." The patent application was filed on Aug. 10, 2007 (11/891,419). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,279,047.PN.&OS=PN/8,279,047&RS=PN/8,279,047 Written by Kusum Sangma; edited by Anand Kumar.

*** Impinj Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Impinj, Seattle, has been assigned a patent (8,279,045) developed by seven co-inventors for an "RFID tag chips and tags refraining from participating in a subsequent inventorying attempt and methods." The co-inventors are Christopher J. Diorio, Shoreline, Wash., Paul Dietrich, Seattle, Theron Stanford, Seattle, Chad Lindhorst, Seattle, Kambiz Rahimi, Bellevue, Wash., Ali Aiouaz, Mission Viejo, Calif., and Aanand Esterberg, Seattle.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "RFID tags and chips for RFID tags are capable of being inventoried in one or more early attempts. These tags are capable of then refraining from participating in one or more subsequent inventorying attempts. In some embodiments refraining is performed solely by the tag, while in others it is guided by the RFID reader. In some embodiments, an inventoried indicator in the tag becomes updated upon backscattering. The updated value is used by the tag to recognize a subsequent attempt, and thus refrain from participating in it. This permits the subsequent attempt to be used more intensively for inventorying the more elusive, harder-to-read tags, especially in more demanding scenarios." The patent application was filed on March 28, 2008 (12/057,467). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,279,045.PN.&OS=PN/8,279,045&RS=PN/8,279,045 Written by Kusum Sangma; edited by Anand Kumar.

*** Genentech Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Genentech, South San Francisco, Calif., has been assigned a patent (8,278,099) developed by Dan L. Eaton, San Rafael, Calif., and Frederic J. de Sauvage, Foster City, Calif., for a "monoclonal antibody to human thrombopoietin." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Isolated thrombopoietin (TPO), isolated DNA encoding TPO, and recombinant or synthetic methods of preparing and purifying TPO are disclosed. Various forms of TPO are shown to influence the replication, differentiation or maturation of blood cells, especially megakaryocytes and megakaryocyte progenitor cells. Accordingly, these compounds may be used for treatment of thrombocytopenia." The patent application was filed on May 3, 1995 (08/433,767). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,278,099.PN.&OS=PN/8,278,099&RS=PN/8,278,099 Written by Kusum Sangma; edited by Anand Kumar.

*** University of California Assigned Patent ALEXANDRIA, Va., Oct. 6 -- The University of California, Oakland, Calif., has been assigned a patent (8,278,112) developed by Kevan Shokat, San Francisco, and Matthew D. Simon, Cambridge, Mass., for a "site-specific installation of methyl-lysine analogues into recombinant histones." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides reagents and methods for the introduction of analogues of methyl or acetyl lysine into histone proteins." The patent application was filed on Dec. 20, 2007 (11/961,956). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,278,112.PN.&OS=PN/8,278,112&RS=PN/8,278,112 Written by Kusum Sangma; edited by Anand Kumar.

*** Danisco US Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Danisco US, Palo Alto, Calif., has been assigned a patent (8,278,079) developed by Nigel Dunn-Coleman, Los Gatos, Calif., and Michael Ward, San Francisco, for a "BGL6 .beta.-glucosidase and nucleic acids encoding the same." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides a novel .beta.-glucosidase nucleic acid sequence, designated bgl6, and the corresponding BGL6 amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding BGL6, recombinant BGL6 proteins and methods for producing the same." The patent application was filed on July 21, 2009 (12/506,745). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,278,079.PN.&OS=PN/8,278,079&RS=PN/8,278,079 Written by Kusum Sangma; edited by Anand Kumar.

*** Xatra Fund MX Assigned Patent ALEXANDRIA, Va., Oct. 6 -- Xatra Fund MX, Wilmington, Del., has been assigned a patent (8,279,042) developed by seven co-inventors for an "iris scan biometrics on a payment device." The co-inventors are Blayn W. Beenau, Peoria, Ariz., David S. Bonalle, New Rochelle, N.Y., Seth W. Fields, Taylorsville, Utah, William J. Gray, Salt Lake City, Carl Larkin, West Sussex, United Kingdom, Joshua L. Montgomery, Orem, Utah, and Peter D. Saunders, For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1101995 (c) 2012 Targeted News Service

[ Back To Homepage ]

Real time alerts

The World's Largest Communications And Technology Community

Technology Marketing Corporation,
800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800; Fx: 203-866-3326
General comments: tmc@tmcnet.com. Comments about this site: webmaster@tmcnet.com.

» About » Contact » Advertise